We recently published 12 Stocks on Jim Cramer’s Radar. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer’s radar.

Pfizer (NYSE:PFE) shares slid about 3% on Tuesday morning after the company lowered its earnings and revenue forecasts for 2026. The pharmaceutical giant now expects earnings per share between $2.80 ...

The drugmaker revised its revenue guidance for 2025, saying it now expects $62 billion in revenue for the year.

Pfizer Inc. is rated a Hold due to structural challenges despite recent 12% total return and compelling 6.7% dividend yield.

Pfizer (NYSE:PFE) shares slid about 5% on Tuesday morning after the company lowered its earnings and revenue forecasts for 2026. The pharmaceutical giant now expects earnings per share between $2.80 ...

Shares in Pfizer ($PFE) inched higher early Tuesday even as the U.S. pharma giant forecast 2026 earnings that are below Wall Street’s ...

Pfizer projected 2026 adjusted earnings per share of $2.80 to $3, below analysts’ expectations of $3.05.

Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to deliver.

Adjusted Earnings Per Share: Pfizer has maintained its adjusted earnings per share outlook for 2025, indicating a steady operational performance. Revenue Forecast Revision: The downward adjustment in ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...

Pfizer (PFE) says its Paxlovid forecast assumes that Covid infection rates will again decline in 2026 and “we expect this will be especially true ...